novo nordisk semaglutide shortage FDA: Nordisk's Ozempic and Wegovy, long in shortage, now available FDA Declares Shortage of Novo

Frequently Asked Questions GLP-1 is a hormone naturally produced by the body that is integral in controlling blood sugar and appetite

Most insurers do cover Ozempic, but only if you have diabetes

In December 2023, the company acquired Lindora, a chain of 31 weight-loss medical clinics in Southern California and Washington state staffed with physicians who prescribe GLP-1s, hormone replacement therapy, and IV hydration

Expanding Indications: The success of Semaglutide in diabetes and weight management has led to ongoing research into its potential use in other areas, such as non-alcoholic fatty liver disease (NAFLD) and even neurodegenerative disorders